Bortezomib in Treating Patients With Malignant Pleural Mesothelioma

NCT00513877 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

NETWORK

Sponsor class

Conditions

Malignant Mesothelioma

Interventions

DRUG: bortezomib
PROCEDURE: quality-of-life assessment

Sponsor

Cancer Trials Ireland